CDK8 Expression Is Associated with β-Catenin Activation and Poor Outcome in Colon Cancer

被引：0
|
作者：
Firestein, R.
Shima, K.
Nosho, K.
Kure, S.
Irahara, N.
Bojarski, E.
Kirkner, G. J.
Hahn, W. C.
Giovannucci, E. L.
Fuchs, C. S.
Ogino, S.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
578
引用
收藏
页码：129A / 129A
页数：1
相关论文
共 50 条
  • [21] CDK8 Expression in Extrauterine Leiomyosarcoma Correlates With Tumor Stage and Progression
    Yergiyev, Oleksandr
    Garib, George
    Schoedel, Karen
    Palekar, Alka
    Goodman, Mark
    Bartlett, David
    Rao, Uma
    MODERN PATHOLOGY, 2015, 28 : 29A - 29A
  • [22] CDK8 Expression in Extrauterine Leiomyosarcoma Correlates With Tumor Stage and Progression
    Yergiyev, Oleksandr
    Garib, George
    Schoedel, Karen
    Palekar, Alka
    Bartlett, David
    Rao, Uma N. M.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (03) : 161 - 164
  • [23] Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure
    Hall, Duane D.
    Ponce, Jessica M.
    Chen, Biyi
    Spitler, Kathryn M.
    Alexia, Adrianne
    Oudit, Gavin Y.
    Song, Long-Sheng
    Grueter, Chad E.
    JCI INSIGHT, 2017, 2 (15):
  • [24] CDK8 Expression in Extrauterine Leiomyosarcoma Correlates With Tumor Stage and Progression
    Yergiyev, Oleksandr
    Garib, George
    Schoedel, Karen
    Pcdekar, Alka
    Goodman, Mark
    Bartlett, David
    Rao, Uma
    LABORATORY INVESTIGATION, 2015, 95 : 29A - 29A
  • [25] CDK8 kinase-An emerging target in targeted cancer therapy
    Rzymski, Tomasz
    Mikula, Michal
    Wiklik, Katarzyna
    Brzozka, Krzysztof
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2015, 1854 (10): : 1617 - 1629
  • [26] Tumor-suppressive effects of CDK8 in endometrial cancer cells
    Gu, Weiting
    Wang, Chenguang
    Li, Weihua
    Hsu, Fu-Ning
    Tian, Lifeng
    Zhou, Jie
    Yuan, Cunzhong
    Xie, Xiao-Jun
    Jiang, Tao
    Addya, Sankar
    Tai, Yanhong
    Kong, Beihua
    Ji, Jun-Yuan
    CELL CYCLE, 2013, 12 (06) : 987 - 999
  • [27] Phosphoproteomic-based identification of CDK8/CDK19 substrates in colorectal cancer
    Popoola, Olajumoke O.
    Samant, Rahul
    Ortiz-Ruiz, Maria-Jesus
    Mallinger, Aurelie
    Court, Will
    Hobbs, Steve
    Te-Poele, Robert
    Stubbs, Mark
    Burke, Rosemary
    Esdar, Christina
    Schiemann, Kai
    Wienke, Dirk
    Eccles, Sue
    Blagg, Julian
    Workman, Paul
    Clarke, Paul
    CANCER RESEARCH, 2016, 76
  • [28] The role of the mediator complex subunits CDK8 and CDK19 in prostate cancer progression
    Offermann, A.
    Hupe, M. C.
    Joerg, V.
    Becker, F.
    Braegelmann, J.
    Merseburger, A. S.
    Kirfel, J.
    Perner, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 46 - 47
  • [29] β-Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma
    Gaujoux, Sebastien
    Grabar, Sophie
    Fassnacht, Martin
    Ragazzon, Bruno
    Launay, Pierre
    Libe, Rossella
    Chokri, Ilham
    Audebourg, Anne
    Royer, Benedict
    Sbiera, Silviu
    Vacher-Lavenu, Marie-Cecile
    Dousset, Bertrand
    Bertagna, Xavier
    Allolio, Bruno
    Bertherat, Jerome
    Tissier, Frederique
    CLINICAL CANCER RESEARCH, 2011, 17 (02) : 328 - 336
  • [30] Expression of SPARC is associated with poor prognosis in human colon cancer
    Naito, Toshikatsu
    Kitadai, Yasuhiko
    Takigawa, Hidehiko
    Yuge, Ryo
    Kuwai, Toshio
    Yasui, Wataru
    Tanaka, Shinji
    Chayama, Kazuaki
    CANCER SCIENCE, 2018, 109 : 1029 - 1029
12345